申请人:GLOBAL BLOOD THERAPEUTICS, INC.
公开号:US11254651B2
公开(公告)日:2022-02-22
The present disclosure provides certain compounds that are histone methyltransferases G9a and/or GLP inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of G9a and/or GLP such as cancers and hemoglobinpathies such as beta-thalassemia and sickle cell disease. Also provided are pharmaceutical compositions containing such compounds as well as processes and intermediates for preparing such compounds.
本公开提供的某些化合物是组蛋白甲基转移酶 G9a 和/或 GLP 抑制剂,因此可用于治疗可通过抑制 G9a 和/或 GLP 治疗的疾病,如癌症和血红蛋白病,如β-地中海贫血和镰状细胞病。此外,还提供了含有此类化合物的药物组合物以及制备此类化合物的工艺和中间体。